Elizabeth Lee, MD, shares that rinatabart sesutecan’s MOA may allow more patients with advanced endometrial cancer to receive effective treatment.
Elizabeth Lee, MD
Advertisement
Elizabeth Lee, MD, is a medical oncologist for the gynecology oncology program at Dana-Farber Cancer Institute in Boston, Massachusetts.
Articles by Elizabeth Lee, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Oncology Nursing News
1
When Are TKIs Too Aggressive for a Patient With Renal Cell Carcinoma?
2
Why Does Rina-S Target Folate Receptor Alpha in Endometrial Cancer?
3
Real-World Data Favor GLP-1 vs Aspirin in Colorectal Cancer Prevention
4
Physical Activity Reduces Colorectal-Cancer–Related Fatigue
5